MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

486158

Report Date :

16.01.2018

 

IDENTIFICATION DETAILS

 

Name :

STERIL-GENE LIFE SCIENCES PRIVATE LIMITED [w.e.f. 26.02.2009]

 

 

Formerly Known As :

STERIGENE LIFE SCIENCES PRIVATE LIMITED

 

 

Registered Office :

New No.15, Old No.7, Gopalakrishnan Road, T. Nagar, Chennai-600017, Tamilnadu

Tel. No.:

91-44-23452030

 

 

Country :

India

 

 

Financials (as on) :

31.03.2016

 

 

Date of Incorporation :

28.02.2007

 

 

Com. Reg. No.:

18-062549

 

 

Capital Investment / Paid-up Capital :

INR 1084.882 Million

 

 

CIN No.:

[Company Identification No.]

U02423TN2007PTC062549

 

 

IEC No.:

Not Divulged

 

 

GST No.:

Not Divulged

 

 

TIN No.:

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAKCS9783R

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing of Pharmaceutical Formulations (Softgel, Hardgel, Tablets, Injections, etc.). [Registered Activity]

 

 

No. of Employees :

Not Available

[We tried to confirm the number of employees but no one is ready to part any information from the company management]

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

B

 

Credit Rating

Explanation

Rating Comments

B

Medium Risk

Business dealings permissible on a regular monitoring basis

 

Maximum Credit Limit :

USD 1593200

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 2007. The company is a pharmaceutical company, manufacturing a range of pharmaceutical preparations like tablets, hard gelatin capsules, soft gelatin capsules, dry syrup, dry powder injections, suspension and liquid injections with lyophilization.

 

Management has not filed its financial record with government department for the year 2017 and same are not available from any other sources.

 

As per the financial of 2016, the company has reported a decline in its revenue as compared to the previous year and has incurred operational losses.

 

The company possesses moderate financial position marked by negative reserve base.

 

Business is active. Payments are reported to be slow.

 

In view of aforesaid, the company can be considered for business dealings on safe and secured trade terms and condition.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.06.2017)

Current Rating

(30.09.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long Term Loans=B (Withdrawal)

Rating Explanation

Risk-prone-credit-quality and carries very high credit risk

Date

08.09.2017

 

 

Rating Agency Name

CRISIL

Rating

Short Term Loans=A4 (Withdrawal)

Rating Explanation

Minimal degree of safety and very high credit risk

Date

08.09.2017

 

Reason for withdrawal: The withdrawal of the rating is at the request of the company and on receipt of a no-dues certificate from the bank.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 16.01.2018.

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION DECLINED

 

MANAGEMENT NON-COOPERATIVE

 

[Contact No: 91-44-23452030-34]

 

[Given number 09381007669 is switch off]

 

 

LOCATIONS

 

Registered Office :

New No.15, Old No.7, Gopalakrishnan Road, T. Nagar, Chennai-600017, Tamilnadu, India

Tel. No.:

91-44-23452030-34

Fax No.:

91-44-23452036

E-Mail :

secretarial@steril-gene.com

hrd@steril-gene.com

bd@steril-gene.com

Website :

http://www.steril-gene.com

 

 

Factory :

45 Main Road, Mangalam Village, Villanur Commune, Pondicherry – 605110 (U.T.), India

Tel. No.:

91-413-2661103

Fax No.:

91-413-2661102

 

 

DIRECTORS

 

AS ON: 31.03.2017

 

Name :

Mr. Sivasamy Nadar Manohar

Designation :

Director

Address :

No.25, Kamala Nagar, Madurai, Chennai – 600002, Tamilnadu, India

Date of Birth/Age :

15.03.1953

Qualification :

M.B.B.S

Date of Appointment :

28.02.2007

PAN No.:

AATPM8720C

DIN No.:

01057515

 

 

Name :

Mr. Sulaiman Abdulhai Mohammed

Designation :

Managing Director

Address :

Old No.16, New No.33/1, Kannadasan Road, T Nagar, Chennai – 600018, Tamilnadu, India

Date of Birth/Age :

01.05.1951

Qualification :

B.Pharm

Date of Appointment :

28.02.2007

PAN No.:

AAGPS0218J

DIN No.:

01186491

 

 

Name :

Zenaida Dizon Balajadia

Designation :

Director

Address :

73, Scout Fernandez Street, Philippines Quezon City 1103 Ph

Date of Birth/Age :

27.02.1953

Qualification :

Bachelor of Science in Mathematics

Date of Appointment :

04.12.2009

DIN No.:

02553550

 

 

Name :

Lloyd Dizon Balajadia

Designation :

Director

Address :

73, SCT Fernandez St. Tomas Morato, Quezon City, 1103 Ph

Date of Birth/Age :

25.10.1979

Qualification :

Doctorate in Medicine,Bachelor of Science in Human Biology

Date of Appointment :

04.12.2009

DIN No.:

02655927

 

 

Name :

Dennis Dizon Balajadia

Designation :

Director

Address :

73 Scout Fernandez Street, Brgy Laging Handa Diliman, Quezon City, 1103 PH

Date of Birth/Age :

27.07.1977

Qualification :

Master in Entrepreneurship

Date of Appointment :

04.12.2009

DIN No.:

02655964

 

 

Name :

Dick Dizon Balajadia

Designation :

Director

Address :

73, Scout Fernandez Street, Quezon City, 01100 PH

Date of Birth/Age :

10.12.1981

Qualification :

Culinary Chief (Course)

Date of Appointment :

04.12.2009

DIN No.:

02874680

 

 

Name :

Maximo Ponce Balajadia

Designation :

Director

Address :

73, Scout Fernandez St, Quezon 1100 Ph

Date of Birth/Age :

26.03.1953

Qualification :

Bachelor of Commerce

Date of Appointment :

04.12.2009

DIN No.:

02907712

 

 

Name :

Mr. Alagappan

Designation :

Director

Address :

Plot 27/2, New Beach Road, Thiruvalluvar Nagar, Thiruvanmiyur, Chennai-600041, Tamilnadu, India

Date of Birth/Age :

02.06.1953

Qualification :

M.B.B.S

Date of Appointment :

10.03.2014

PAN No.:

AAHPA8971F

DIN No.:

05215147

 

 

Name :

Mr. Krishnamurthy Balakumar

Designation :

Director

Address :

27a/11a, Moosa Street, T. Nagar, Chennai-600017, Tamilnadu, India

Date of Birth/Age :

13.09.1952

Qualification :

M.B.B.S

Date of Appointment :

10.03.2014

DIN No.:

05215155

 

 

Name :

Mr. Kannappan Nagappan

Designation :

Director

Address :

2d The South Gate 35 Kasturi Ranga Road, Alwarpet, Chennai-600018, Tamilnadu, India

Date of Birth/Age :

01.06.1952

Qualification :

M.B.B.S

Date of Appointment :

10/03/2014

PAN No.:

AABPN0303Q

DIN No.:

05216579

 

 

Name :

Chanpreet Singh Anand

Designation :

Wholetime Director

Address :

Y 234 6th, Main Road, Anna Nagar, Chennai-600040, Tamilnadu, India

Date of Birth/Age :

28.04.1985

Qualification :

Post Graduate/Master/Equivalent

Date of Appointment :

20.03.2015

PAN No.:

AODPA3035Q

DIN No.:

07107578

 

 

KEY EXECUTIVES

 

Name :

Mr. Ramamurthy Jayaraman

Designation :

Company Secretary

Address :

2 (26), Kanaka Sabai Colony, Kamaraj Street Koyambedu, Chennai-600107, Tamilnadu, India

Date of Appointment :

28.06.2017

PAN No.:

AGXPJ2402Q

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON: 31.03.2016

 

Names of Shareholders [Equity Shares]

 

No. of Shares

 

A.M. Sulaiman

 

2000

A.L. Gandhimathi

 

2000

N. Meenakshy

 

2000

B. Mangaleswari

 

2000

S. Manohar

 

2000

A.M. Sulaiman for Accent Pharma

 

18010000

Tristar Formulations Private Limited, India

 

4300000

Star Trends Holding Corp., Hong Kong

 

1083982

Madras Pharma Holdings Private Limited, India

 

30174123

Lloyd Laboratories INC., Phillipines

 

51410141

 

 

 

Total

 

 

104988246

 

Names of Shareholder [Preference Shares]

 

No. of Shares

 

Softgel Healthcare Private Limited, India

 

3500000

 

 

 

Total

 

 

3500000

 

 

AS ON: 21.09.2016

 

Equity Share Breakup

Percentage of Holding

Category

 

Promoters – Individual/ Hindu Undivided Family – Indian

17.16

Promoters – Body Corporate

32.84

Promoters – Others [Foreign body corporates]

50.00

 

 

Total

 

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing of Pharmaceutical Formulations (Softgel, Hardgel, Tablets, Injections, etc.). [Registered Activity]

 

 

Products/ Services :

ITC Code No.

 

Product Descriptions

30043919

Softgelatin Capsules

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Not Divulged

 

 

Purchasing :

Not Divulged

 

PRODUCTION STATUS: (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

Customers :

 

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

No. of Employees :

Not Available

[We tried to confirm the number of employees but no one is ready to part any information from the company management]

 

 

Bankers :

·         Indian Overseas Bank

Commercial and Institutional Credit Branch, No.98A, Dr. Radhakrishnan Salai, Mylapore, Chennai - 600004, Tamilnadu, India

 

·         HDFC Bank Limited

 

 

Facilities :

SECURED LOANS

31.03.2016

(INR In Million)

31.03.2015

(INR In Million)

LONG-TERM BORROWINGS

 

 

Term loans from banks

224.500

180.611

 

 

 

SHORT TERM BORROWINGS

 

 

Loans repayable on demand from banks

48.789

50.156

 

 

 

Total

 

273.289

230.767

 

 

 

Auditors :

 

Name :

B. Srinivasan and Company

Chartered Accountants

Address :

No, 3, Playground View Street, Nandanam Extension, Chennai-600035, Tamilnadu, India

PAN No.:

AAAPB8683L

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Others Related Parties :

·         The Madras Pharmaceuticals

·         Madras Pharma Holdings Private Limited, India [U65990TN2010PTC075670]

·         Maral Labs

·         Accent Pharma

·         Softgel Healthcare Private Limited, India [U24231TN2003PTC051829]

·         Tristar Formulations Private Limited, India [U24231PY2004PTC001758]

·         Euro Healthcare Exponents Inc

 


 

CAPITAL STRUCTURE

 

AS ON: 31.03.2016

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

105000000

Equity Shares

INR 10/- each

INR 1050.000 Million

5000000

Preference Shares

INR 10/- each

INR 50.000 Million

 

Total

 

INR 1100.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

104988246

Equity Shares

INR 10/- each

INR 1049.882 Million

3500000

Preference Shares

INR 10/- each

INR 35.000 Million

 

Total

 

INR 1084.882 Million

 


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2016

31.03.2015

31.03.2014

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

1084.882

1069.882

1049.882

(b) Reserves and Surplus

(527.255)

(457.817)

(312.222)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

557.627

612.065

737.660

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

797.577

529.357

390.240

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long-term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

797.577

529.357

390.240

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

48.789

50.156

47.852

(b) Trade payables

66.779

81.295

72.205

(c) Other current liabilities

79.881

82.031

111.471

(d) Short-term provisions

129.218

93.391

28.166

Total Current Liabilities (4)

324.667

306.873

259.694

 

 

 

 

TOTAL

1679.871

1448.295

1387.594

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1064.445

1097.075

1153.168

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Tangible assets capital work-in-progress

227.367

109.347

88.181

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term loans and advances

19.808

8.262

9.487

(e) Other Non-current assets

89.939

0.000

0.000

Total Non-Current Assets

1401.559

1214.684

1250.836

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

30.852

19.812

31.570

(c) Trade receivables

94.530

98.107

45.055

(d) Cash and bank balances

12.263

5.210

8.052

(e) Short-term loans and advances

0.069

1.971

2.174

(f) Other current assets

140.598

108.511

49.907

Total Current Assets

278.312

233.611

136.758

 

 

 

 

TOTAL

1679.871

1448.295

1387.594

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2016

31.03.2015

31.03.2014

 

SALES

 

 

 

 

Total Revenue from operations

325.314

363.736

352.827

 

Other Income

1.139

0.543

0.868

 

TOTAL

326.453

364.279

353.695

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

153.005

209.457

215.562

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(1.385)

0.822

(1.027)

 

Employee benefit expense

48.087

72.892

49.873

 

Other expenses

80.494

104.206

80.710

 

TOTAL

280.201

387.377

345.118

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

46.252

(23.098)

8.577

 

 

 

 

 

Less

FINANCIAL EXPENSES

36.567

44.978

45.877

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

9.685

(68.076)

(37.300)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

79.124

77.519

50.202

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

(69.439)

(145.595)

(87.502)

 

 

 

 

 

Less

TAX

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

(69.439)

(145.595)

(87.502)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

256.266

48.152

40.542

 

TOTAL EARNINGS

256.266

48.152

40.542

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

7.563

0.000

0.000

 

Components and spare parts

0.179

0.648

0.000

 

Capital Goods

15.197

15.218

0.000

 

TOTAL IMPORTS

22.939

15.865

0.000

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

(0.66)

(1.39)

(0.83)

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Current Maturities of Long term debt

42.000

42.000

79.239

 

 

 

 

Net cash flows from (used in) operations

(75.021)

(74.388)

22.198

 

 

 

 

Net cash flows from (used in) operating activities

(75.021)

(74.388)

22.198

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Average Collection Days

(Sundry Debtors / Income * 365 Days)

106.06

98.45

46.61

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

3.44

3.71

7.83

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

159.30

141.66

122.26

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

1.50

(1.17)

0.27

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.04

(0.02)

0.01

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.69

0.61

0.53

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

1.59

1.02

0.70

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.58

0.50

0.35

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

2.32

1.97

1.68

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

1.26

(0.51)

0.19

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2016

31.03.2015

31.03.2014

Net Profit Margin

((PAT / Sales) * 100)

%

(21.35)

(40.03)

(24.80)

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

(4.13)

(10.05)

(6.31)

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

(12.45)

(23.79)

(11.86)

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Current Ratio

(Current Assets / Current Liabilities)

0.86

0.76

0.53

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.76

0.70

0.41

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.33

0.42

0.53

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

0.82

0.58

0.49

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

0.86

0.76

0.53

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 


 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2014

31.03.2015

31.03.2016

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

1049.882

1069.882

1084.882

Reserves & Surplus

(312.222)

(457.817)

(527.255)

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

737.660

612.065

557.627

 

 

 

 

Long-term borrowings

390.240

529.357

797.577

Short term borrowings

47.852

50.156

48.789

Current maturities of long-term debts

79.239

42.000

42.000

Total borrowings

517.331

621.513

888.366

Debt/Equity ratio

0.701

1.015

1.593

 

 


 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2014

31.03.2015

31.03.2016

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

352.827

363.736

325.314

 

 

3.092

(10.563)

 

 


 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2014

31.03.2015

31.03.2016

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

352.827

363.736

325.314

Profit/ (Loss)

(87.502)

(145.595)

(69.439)

 

(24.80 %)

(40.03 %)

(21.35 %)

 

 

 


 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

No

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

INDEX OF CHARGES

 

SNO

SRN

CHARGE ID

CHARGE HOLDER NAME

DATE OF CREATION

DATE OF MODIFICATION

DATE OF SATISFACTION

AMOUNT

ADDRESS

1

G54131222

100083924

HDFC BANK LIMITED

31/12/2016

18/07/2017

-

336500000.0

HDFC BANK HOUSESENAPATI BAPAT MARGLOWER PAREL WMUMBAIMH400013IN

2

G36201812

10379375

State Bank of India

10/09/2012

10/03/2016

20/02/2017

413500000.0

Overseas Branch86, Rajaji SalaiChennaiTN600001IN

3

C58317447

10109122

Indian Overseas Bank

26/05/2008

26/12/2014

03/07/2015

151700000.0

Commercial & Institutional Credit BranchDr.R.K Salai, MylaporeChennaiTN600004IN

 

 

 

 

UNSECURED LOANS

 

PARTICULARS

31.03.2016

(INR In Million)

31.03.2015

(INR In Million)

LONG-TERM BORROWINGS

 

 

Loans and advances from directors

42.900

26.400

Loans and advances from others

530.177

322.346

 

 

 

Total

 

573.077

348.746

 

 

BRIEF DESCRIPTION OF THE COMPANYS WORKING DURING THE YEAR

 

The Sales of the company recorded a decrease of 10.42 % compared to last year. We are expecting more orders for our facilities and confident of achieving an increase in turnover during the year 2016 - 2017.

 

During the year esteemed representatives from the global players in pharmaceutical formulations and leading players in Indian Pharmaceutical Companies duly visited our facility.

 

 

 

 

 

OUTLOOK :

 

Registration process of our products is going on in many countries like Costa Rica, Republic of Benin, Mali, Ghana, Peru, Malaysia, Columbia, Brazil, Chad, Cameroon, Honduras, Kenya, Cambodia, Armenia, Belarus, Moldova, Tajikistan, etc.

 

They are been exporting their products to South American Express (Bolivia), State Pharmaceutical Corporation (Sri Lanka), Mission Pharma (Denmark / Mali), United Laboratories Inc. (Phillipines) and Lloyd Laboratories Inc. (Philippines) during the year.

 

 

CONTINGENT LIABILITIES:

 

Particulars

31.03.2016

(INR In Million)

31.03.2015

(INR In Million)

Claims against company not acknowledged as debt

0.808

0.586

Guarantees

6.403

6.254

Other money for which company is contingently liable

12.258

0.000

 

 

 

Total

 

19.469

6.840


FIXED ASSETS:

 

Tangible Assets

 

·         Land

·         Buildings

·         Plant and Equipment

·         Furniture and Fixtures

·         Vehicles

·         Office Equipment

·         Computer Equipments

 

 

 

 

 

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 63.41

UK Pound

1

INR 87.18

Euro

1

INR 77.45

 

 

INFORMATION DETAILS

 

Information Gathered by :

KMN

 

 

Analysis Done by :

NIY

 

 

Report Prepared by :

IND

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.